CLT(-) | CLT(+) | Χ2/t-test | P-value | |||
---|---|---|---|---|---|---|
Count | % | Count | % | |||
Gender | ||||||
Female | 107 | (13.7) | 45 | (6.3) | 1.874 | 0.171 |
Male | 17 | (86.3) | 3 | (93.8) | ||
Age (Mean ±S.D) | 50.06±11.51 | 46.44±10.62 | 1.893 | 0.060 | ||
< 45 | 39 | (31.5) | 21 | (43.8) | 2.304 | 0.129 |
≥ 45 | 85 | (68.5) | 27 | (56.3) | ||
Tumor Size(mm)(Mean ±S.D) | 0.92 ±0.73 | 0.88±0.69 | 0.383 | 0.702 | ||
< 1.0 cm | 90 | (72.6) | 34 | (70.8) | 0.908 | 0.635 |
≥ 1.0 cm | 34 | (27.4) | 14 | (29.2) | ||
Multifocality | ||||||
Absent | 94 | (75.8) | 35 | (72.9) | 0.154 | 0.695 |
Present | 30 | (24.2) | 13 | (27.1) | ||
Bilaterality | ||||||
Absent | 101 | (81.5) | 38 | (79.2) | 0.117 | 0.733 |
Present | 23 | (18.5) | 10 | (20.8) | ||
Extrathyroidal extension | ||||||
Absent | 76 | (61.3) | 34 | (70.8) | 1.367 | 0.242 |
Present | 48 | (38.7) | 14 | (29.2) | ||
Central LM metastasis | ||||||
Absent | 66 | (53.2) | 32 | (66.7) | 2.550 | 0.110 |
Present | 58 | (46.8) | 16 | (33.3) | ||
Lateral LM metastasis | ||||||
Absent | 110 | (88.7) | 44 | (91.7) | 0.323 | 0.570 |
Present | 14 | (11.3) | 4 | (8.3) | ||
TNM stage | ||||||
I & II | 71 | (57.3) | 36 | (75.0) | 5.770 | 0.056 |
III | 40 | (32.3) | 11 | (22.9) | ||
IVa | 13 | (10.5) | 1 | (2.1) | ||
BRAF mutation | ||||||
Negative | 22 | (17.7) | 20 | (41.7) | 10.732 | 0.001 |
Positive | 102 | (82.3) | 28 | (58.3) |